labetalol has been researched along with Delayed Effects, Prenatal Exposure in 7 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypotension is more common after maternal labetalol exposure, regardless of the dosage and route of administration." | 5.38 | Neonatal side effects of maternal labetalol treatment in severe preeclampsia. ( Heida, KY; Hulzebos, CV; Van Veen, TR; Zeeman, GG, 2012) |
| "Nine mothers were treated with labetalol and/or MgSO4 during pregnancy, three mothers with labetalol, MgSO4 and nifedipine, and 19 mothers with nifedipine only." | 3.79 | Maternal antihypertensive drugs may influence cerebral oxygen extraction in preterm infants during the first days after birth. ( Bos, AF; Kooi, EM; van den Berg, PP; Verhagen, EA, 2013) |
| "To determine the functional development of children born after treatment of mild-to-moderate gestational hypertension with labetalol versus methyldopa, and no antihypertensive treatment." | 3.76 | Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study. ( Eskes, TK; Gabreëls, FJ; Pasker-de Jong, PC; Pellegrino, A; van Gelder, MM; Zielhuis, GA, 2010) |
| "Two infants with features of severe beta adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy." | 3.70 | Adverse neonatal effects of maternal labetalol treatment. ( Crooks, BN; Deshpande, SA; Hall, C; Milligan, DW; Platt, MP, 1998) |
| "Hypotension is more common after maternal labetalol exposure, regardless of the dosage and route of administration." | 1.38 | Neonatal side effects of maternal labetalol treatment in severe preeclampsia. ( Heida, KY; Hulzebos, CV; Van Veen, TR; Zeeman, GG, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thewissen, L | 1 |
| Pistorius, L | 1 |
| Baerts, W | 1 |
| Naulaers, G | 1 |
| Van Bel, F | 1 |
| Lemmers, P | 1 |
| Pasker-de Jong, PC | 1 |
| Zielhuis, GA | 1 |
| van Gelder, MM | 1 |
| Pellegrino, A | 1 |
| Gabreëls, FJ | 1 |
| Eskes, TK | 1 |
| Chan, WS | 1 |
| Koren, G | 1 |
| Barrera, M | 1 |
| Rezvani, M | 1 |
| Knittel-Keren, D | 1 |
| Nulman, I | 1 |
| Heida, KY | 1 |
| Zeeman, GG | 1 |
| Van Veen, TR | 1 |
| Hulzebos, CV | 1 |
| Daskas, N | 1 |
| Crowne, E | 1 |
| Shield, JP | 1 |
| Verhagen, EA | 1 |
| Kooi, EM | 1 |
| van den Berg, PP | 1 |
| Bos, AF | 1 |
| Crooks, BN | 1 |
| Deshpande, SA | 1 |
| Hall, C | 1 |
| Platt, MP | 1 |
| Milligan, DW | 1 |
7 other studies available for labetalol and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Neonatal haemodynamic effects following foetal exposure to labetalol in hypertensive disorders of pregnancy.
Topics: Antihypertensive Agents; Blood Pressure; Case-Control Studies; Cerebrum; Female; Gestational Age; He | 2017 |
Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study.
Topics: Antihypertensive Agents; Attention; Attention Deficit Disorder with Hyperactivity; Bed Rest; Child; | 2010 |
Neurocognitive development of children following in-utero exposure to labetalol for maternal hypertension: a cohort study using a prospectively collected database.
Topics: Adult; Analysis of Variance; Child; Child Development; Child, Preschool; Databases, Factual; Female; | 2010 |
Neonatal side effects of maternal labetalol treatment in severe preeclampsia.
Topics: Adult; Antihypertensive Agents; Case-Control Studies; Female; Fetal Death; Humans; Infant Mortality; | 2012 |
Is labetalol really a culprit in neonatal hypoglycaemia?
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Female; Humans; Hypertension; Hypoglycemia; In | 2013 |
Maternal antihypertensive drugs may influence cerebral oxygen extraction in preterm infants during the first days after birth.
Topics: Antihypertensive Agents; Case-Control Studies; Cerebral Cortex; Cerebrovascular Circulation; Female; | 2013 |
Adverse neonatal effects of maternal labetalol treatment.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Cardiomegaly; Dobutamine; Dopamine; Dr | 1998 |